Monkeypox Therapeutics Market
Monkeypox Therapeutics Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Monkeypox Therapeutics Market Size and Growth
The Monkeypox therapeutics market is experiencing significant growth due to rising incidence rates and increasing awareness. As of 2023, the market size is estimated to reach approximately USD 100 million, driven by advancements in antiviral treatments and vaccines. Current research focuses on effective therapies to address outbreak preparedness and response. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Chimerix Inc.
◍ SIGA Technologies
◍ Inc.
◍ Emergent BioSolutions Inc.
◍ Bavarian Nordic A/S
◍ Hetero Drugs Limited
◍ Mylan N.V.
◍ Piramal Enterprises Limited
◍ Olon S.p.A.
The Monkeypox therapeutics market comprises companies like Chimerix, SIGA Technologies, and Bavarian Nordic, focusing on antiviral therapies and vaccines. These firms enhance market growth through innovative products and strategic partnerships. Sales figures for select companies may include:
- SIGA Technologies: $34.4 million (2022)
- Emergent BioSolutions: $688 million (2022)
◍ Teva Pharmaceutical Industries Limited
◍ CIDIC Company Limited
- Bavarian Nordic: $665 million (2022) Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Specialty Clinics
◍ Ambulatory Surgical Centers
◍ Others
By Product
◍ Smallpox Vaccine ◍ Antivirals
◍ Vaccinia Immune Globulin (VIG)
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
